清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

PB1660 FLOW CYTOMETRY CHALLENGE FOR MEASURABLE RESIDUAL DISEASE MONITORING IN B-ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) PATIENTS RECEIVING TARGETED IMMUNOTHERAPY

作者
Ana Yeguas Bermejo,A. Martín García-Sancho,Noemí Puig Morón,M. P. Leoz Allegretti,Víctor Saavedra,I. Aires Mejía,C. Casquero Hernández,L. López Corral,Estefanía Pérez López,Ana África Martín López,Félix López Cadenas,Alba Redondo Guijo,Álvaro Veiga Vaz,E. Sobejano Fuertes,Marta Fonseca Santos,D. Presa Morales,R. Azibeiro Melchor,D. Rivera Delgado,Jesús María Hernández‐Rivas,M. González Díaz
出处
期刊:HemaSphere [Wolters Kluwer]
卷期号:3 (S1): 768-768
标识
DOI:10.1097/01.hs9.0000564888.15935.a8
摘要

Background: Targeted immunotherapy (TI) with Blinatumomab (Bln) or Inotuzumab ozogamicin (IO) are a salvage option for the management of B-ALL patients with measurable residual disease (MRD), in which high rates of MRD negative can be achieved, allowing a bridge to transplantation and longer survival. However, some patients relapse with a phenotype lacking CD19 or CD22 expression can be found in blast cells. Those escape variants have also been described under CAR-T cells therapy, and different mechanism of escape have been proposed. This resistance mechanism has to be considered in flow cytometry immunophenotyping (FCM) analysis when monitoring MRD. Aims: Review the MRD monitoring by FCM in patients diagnosed of B-LLA treated with TI in our center that experience relapse. Methods: Two B-ALL patients treated in our center with TI experienced relapse. The FCM monitoring were performed in BMA samples, using 8-colour combinations of monoclonal antibodies adapted to the TI received and diagnosis phenotype. Stained cells were measured in FACSCanto II cytometer equipped with the FACSDiva software and analyzed with the Infinicyt software with a sensitivity (S) 10-4. Results: Between 2015 and 2018, 2 B-LLA patients relapsed after TI. One of them relapsed with the same phenotype previously detected, and the other patient experienced two relapses, the first one after Bln and then after IO. Interestingly, both relapses showed immunophenotypic changes (figure). The patient was a 72 years old woman that initially received treatment according to PETHEMA-LAL-OLD-07 protocol. Bone marrow aspiration (BMA) at the end of induction was in morphological complete response (CR) with MRD positive (0.12%). After 3rd consolidation cycle, MRD persisted (0.04%), so she started Bln and achieved MRD negative (S 10-4) after 1st cycle. However, after the 3rd cycle, a new CD19- blast cell population was detected (0.07%), with a lower expression of CD20, being the remaining markers similar to the diagnostic. In normal B cells (0.05%) the intensity of CD19 expression was preserved. Blast cells increased after 4th cycle (2.9%) with an associated morphological relapse (21%). She started IO treatment and reached CR and MRD negative (S 10-4) after 1st cycle. Treatment was stopped after the 4th cycle due to upper gastrointestinal bleeding, and in the BMA previous to the next cycle programmed, CD19- CD20dim CD34+ blast cells were detected again (0.55%). All blasts lost CD22 expression, and only 9% maintained the CD10 expression detected previously, being the majority CD10 negative. The patient was not candidate to any other therapy, she started palliative treatment and died 2 months later.Summary/Conclusion: In our experience, changes in immunophenotype of B-ALL blast cells are frequent after TI, due to loss of CD19 and CD22 expression. Therefore, FCM analysis in patients treated with TI demands a high degree of expertise and attention, to avoid the loss of detection of new populations that could emerge with different phenotype.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小清完成签到,获得积分10
3秒前
Aaron完成签到,获得积分10
22秒前
27秒前
34秒前
桐桐的应助被葛力采纳,获得10
42秒前
脑洞疼的应助被矢思然采纳,获得10
42秒前
1分钟前
李爱国的应助被搞怪的方盒采纳,获得30
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
烟花的应助被开朗的尔蝶采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
幸福丹蝶完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
叫啥好呢完成签到 ,获得积分10
2分钟前
clairewen完成签到,获得积分10
2分钟前
2分钟前
2分钟前
3分钟前
3分钟前
3分钟前
矢思然发布了新的文献求助10
3分钟前
3分钟前
葛力发布了新的文献求助10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
4分钟前
NN的应助被萧雨墨采纳,获得10
4分钟前
123完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577282
关于积分的说明 21852326
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436298
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902